These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10960842)

  • 21. Persistence of high-grade prostatic intra-epithelial neoplasia under combined androgen blockade therapy.
    van der Kwast TH; Labrie F; Tetu B
    Hum Pathol; 1999 Dec; 30(12):1503-7. PubMed ID: 10667430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neoadjuvant hormonal deprivation before radical prostatectomy.
    Schulman CC; Sassine AM
    Clin Invest Med; 1993 Dec; 16(6):523-31. PubMed ID: 7516836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of combination endocrine therapy (LHRH agonist and flutamide) on normal prostate and prostatic adenocarcinoma. A histopathologic and immunohistochemical study.
    Têtu B; Srigley JR; Boivin JC; Dupont A; Monfette G; Pinault S; Labrie F
    Am J Surg Pathol; 1991 Feb; 15(2):111-20. PubMed ID: 1989458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostatic adenocarcinoma with glomeruloid features.
    Pacelli A; Lopez-Beltran A; Egan AJ; Bostwick DG
    Hum Pathol; 1998 May; 29(5):543-6. PubMed ID: 9596281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin-like growth factor-1 is associated with regulation of the luteinizing hormone production in men receiving androgen deprivation therapy with gonadotropin-releasing hormone analogues for localized prostate cancer.
    Hara N; Takizawa I; Isahaya E; Nishiyama T; Hoshii T; Ishizaki F; Takahashi K
    Urol Oncol; 2012 Sep; 30(5):596-601. PubMed ID: 21458314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen-independent status.
    Hong H; Kao C; Jeng MH; Eble JN; Koch MO; Gardner TA; Zhang S; Li L; Pan CX; Hu Z; MacLennan GT; Cheng L
    Cancer; 2004 Jul; 101(1):83-9. PubMed ID: 15221992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BP1, a homeoprotein, is significantly expressed in prostate adenocarcinoma and is concordant with prostatic intraepithelial neoplasia.
    Schwartz AM; Man YG; Rezaei MK; Simmens SJ; Berg PE
    Mod Pathol; 2009 Jan; 22(1):1-6. PubMed ID: 18931648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of macrophage migration inhibitory factor in the human prostate.
    Meyer-Siegler K; Fattor RA; Hudson PB
    Diagn Mol Pathol; 1998 Feb; 7(1):44-50. PubMed ID: 9646034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inference network-based analyses of the histopathological effects of androgen deprivation on prostate cancer.
    Montironi R; Santinelli A; Pomante R; Hamilton PW; Thompson D; Bartels PH
    J Pathol; 1999 Mar; 187(4):462-8. PubMed ID: 10398107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced expression of macrophage migration inhibitory factor in prostatic adenocarcinoma metastases.
    Meyer-Siegler K; Hudson PB
    Urology; 1996 Sep; 48(3):448-52. PubMed ID: 8804500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroendocrine cells in benign prostatic hyperplasia and prostatic carcinoma: effect of hormonal treatment.
    Guate JL; Escaf S; Menendez CL; del Valle M; Vega JA
    Urol Int; 1997; 59(3):149-53. PubMed ID: 9428430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Neuroendocrine differentiation in adenocarcinoma of the prostate with progression of disease during hormonal treatment: a report of two cases].
    Kosugi M; Hanawa Y; Momma T; Saito S; Hirose S
    Nihon Hinyokika Gakkai Zasshi; 2003 May; 94(4):521-4. PubMed ID: 12795167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preliminary results of a prospective randomized study comparing radical prostatectomy versus radical prostatectomy associated with neoadjuvant hormonal combination therapy in T2-3 N0 M0 prostatic carcinoma. The European Study Group on Neoadjuvant Treatment of Prostate Cancer.
    Witjes WP; Schulman CC; Debruyne FM
    Urology; 1997 Mar; 49(3A Suppl):65-9. PubMed ID: 9123739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Localized amyloidosis of the seminal vesicle. Possible association with hormonally treated prostatic adenocarcinoma.
    Unger PD; Wang Q; Gordon RE; Stock R; Stone N
    Arch Pathol Lab Med; 1997 Dec; 121(12):1265-8. PubMed ID: 9431316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative immunohistochemical analysis of insulin-like growth factor binding protein-3 in human prostatic adenocarcinoma: a prognostic study.
    Hampel OZ; Kattan MW; Yang G; Haidacher SJ; Saleh GY; Thompson TC; Wheeler TM; Marcelli M
    J Urol; 1998 Jun; 159(6):2220-5. PubMed ID: 9598573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of neoadjuvant endocrine therapy (combined androgen blockade) on normal prostate and prostatic carcinoma. A randomized study.
    Vailancourt L; Ttu B; Fradet Y; Dupont A; Gomez J; Cusan L; Suburu ER; Diamond P; Candas B; Labrie F
    Am J Surg Pathol; 1996 Jan; 20(1):86-93. PubMed ID: 8540613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of total androgen ablation on pathologic stage and resection limit status of prostate cancer. Initial results of the Italian PROSIT study.
    Montironi R; Diamanti L; Santinelli A; Galetti-Prayer T; Zattoni F; Selvaggi FP; Pagano F; Bono AV
    Pathol Res Pract; 1999; 195(4):201-8. PubMed ID: 10337657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of combined endocrine therapy on prostate and testis].
    Kong X; Zeng L; Xia T; Wang J; Mi P; Na Y; Xue Z; Pan B; Hao J; Gu F; Guo Y
    Zhonghua Wai Ke Za Zhi; 1999 Apr; 37(4):231-4. PubMed ID: 11829828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
    Tavora F; Epstein JI
    Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does small-cell phenotype predict the natural history of prostate cancer? A case study in disease behavior.
    Slovin SF
    Nat Clin Pract Oncol; 2007 Sep; 4(9):551-4. PubMed ID: 17728713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.